Biohaven Stock Down Fund's Turnaround Bet Sparks Hope
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Review today’s 30-year mortgage rate chart to compare trends and identify favorable rates across lenders.
23,821 articlesA patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
A quiet, data-driven move by Endeavour Capital Advisors boosted its stake in QCR Holdings in Q1 2026. Learn what this...
The EMB ETF offers a ~6% yield on USD EM debt, but a hidden sovereign default risk can erode income and NAV during ma...
Super Micro Computer stunned investors with a colossal AI server backlog, but a planned $7 billion capital raise trig...
Space-focused investors have watched Redwire stock keep dropping as headlines swirl about contracts, funding, and exe...
June 2026 looked like a milestone month for Oklo, but the stock went the other way. This deep dive explains why the s...
When a TV showdown becomes a real-world rental, fans race to lock in a stay and lenders notice. This article breaks d...
A telecom giant surprised investors with a sharp month-long rally. This article breaks down the factors behind Verizo...
Public discourse and online search data can sway our money choices more than we realize. This article breaks down how...
If you’re weighing Peloton as an investment, you’re not alone. This piece lays out two essential reasons I haven’t bo...
Citigroup has quietly strengthened its fundamentals while stock performance has turned a corner. This guide breaks do...
U.S. stocks surged, with the S&P 500 hitting a fresh peak and a new company joining the $1 trillion market-cap circle...